Referred Tests
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing. | |
Test ID: GDF15
Growth Differentiation Factor 15, Plasma
Useful For 
Suggests clinical disorders or settings where the test may be helpful
A circulating biomarker in myopathy-related mitochondrial disease as well as other conditions
Investigation of patients suspected of having a mitochondrial myopathy
This assay is not suitable for carrier detection.
Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
See Epilepsy: Unexplained Refractory and/or Familial Testing Algorithm in Special Instruction.
Special Instructions Library of PDFs including pertinent information and forms related to the test
Method Name A short description of the method used to perform the test
Enzyme-Linked Immunosorbent Assay (ELISA)
NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Reporting Name Lists a shorter or abbreviated version of the Published Name for a test
Growth Differentiation Factor 15, P
Aliases Lists additional common names for a test, as an aid in searching
Growth Differentiation Factor 15
GDF15
Alpers Disease
Barth Syndrome (3-Methylglutaconic Aciduria, Type II)
Ataxia Neuropathy Syndrome (ANS)
CoEnzyme Q10 Deficiency
Complex I Deficiency
Complex II Deficiency
Complex III Deficiency
Complex IV Deficiency
Complex V Deficiency
Cytochrome C Oxidase (COX) Deficiency
Chronic Progressive External Ophthalmoplegia (CPEO)
Kearns-Sayre syndrome (KSS)
Lactic Acidosis
Leber's Hereditary Optic Neuropathy (LHON)
Leigh Disease or Syndrome
Myoclonic Epilepsy, Myopathy, Sensory Ataxia (MEMSA)
Mitochondrial encephalomyopathy lactic acidosis, and stroke-like episodes (MELAS)
Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)
Mitochondrial Recessive Ataxia Syndrome (MIRAS)
Mitochondrial Cytopathy
Mitochondrial DNA Depletion
Mitochondrial Encephalopathy
Mitochondrial Myopathy
Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)
Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)
Pearson Syndrome
Pyruvate Carboxylase Deficiency
Pyruvate Dehydrogenase Deficiency
POLG Mutations
Respiratory Chain Defects
Sensory Ataxia, Neuropathy, Dysarthria, Ophthalmoplegia (SANDO)
Spinocerebellar Ataxia with Epilepsy (SCAE)
Mitochondrial biomarker
GDF15
Alpers Disease
Barth Syndrome (3-Methylglutaconic Aciduria, Type II)
Ataxia Neuropathy Syndrome (ANS)
CoEnzyme Q10 Deficiency
Complex I Deficiency
Complex II Deficiency
Complex III Deficiency
Complex IV Deficiency
Complex V Deficiency
Cytochrome C Oxidase (COX) Deficiency
Chronic Progressive External Ophthalmoplegia (CPEO)
Kearns-Sayre syndrome (KSS)
Lactic Acidosis
Leber's Hereditary Optic Neuropathy (LHON)
Leigh Disease or Syndrome
Myoclonic Epilepsy, Myopathy, Sensory Ataxia (MEMSA)
Mitochondrial encephalomyopathy lactic acidosis, and stroke-like episodes (MELAS)
Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)
Mitochondrial Recessive Ataxia Syndrome (MIRAS)
Mitochondrial Cytopathy
Mitochondrial DNA Depletion
Mitochondrial Encephalopathy
Mitochondrial Myopathy
Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)
Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)
Pearson Syndrome
Pyruvate Carboxylase Deficiency
Pyruvate Dehydrogenase Deficiency
POLG Mutations
Respiratory Chain Defects
Sensory Ataxia, Neuropathy, Dysarthria, Ophthalmoplegia (SANDO)
Spinocerebellar Ataxia with Epilepsy (SCAE)
Mitochondrial biomarker